NCT05502965

Brief Summary

Over the past 10 years, there are a large number of dietary treatments related to the CD, such as specific carbohydrate diet, low Fermentable Oligo-, Di-, Mono-saccharides And Polyols (FODMAP) diet, and allergen-free foods. But there is no consistent conclusion or convincing evidence about the effectiveness. Through the long-term clinical experience observation, we find most of the CD patients can get stable remission by removing refined food and intolerance food.This project aims at developing a new dietary therapy suitable for Chinese patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Sep 2022Jun 2026

First Submitted

Initial submission to the registry

August 11, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 16, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

September 17, 2022

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

3.8 years

First QC Date

August 11, 2022

Last Update Submit

January 29, 2026

Conditions

Keywords

Dietary Pattern, Crohn Disease

Outcome Measures

Primary Outcomes (1)

  • Quality of Life(IBDQ)

    IBDQ: Inflammatory Bowel Disease Questionnaire.The IBDQ evaluates the quality of life of patients from four aspects: intestinal symptoms, systemic symptoms, emotional function and social function. There are 32 questions in the questionnaire, with a total score of 32 to 224 points. The higher the score, the higher the quality of life of the patient.

    The two groups of patients were scored at first week and sixth week after surgery.

Secondary Outcomes (2)

  • nutritional status of the patient

    The two groups were evaluated at first week and sixth week after surgery.

  • Disease-related evaluation indicators

    The two groups were evaluated at first week and sixth week after surgery.

Other Outcomes (1)

  • dietary compliance

    The two groups were evaluated at sixth week after surgery.

Study Arms (2)

Exclusive Enteral Nutrition(EEN)

ACTIVE COMPARATOR

Subjects required exclusive enteral nutrition for one month

Other: EEN

Specific Diet+ Partial Enteral Nutrition

EXPERIMENTAL

Subjects received partial enteral nutrition with remaining energy and nutrients obtained through diet for one month

Other: dietary pattern

Interventions

Reprocessed and intolerant foods were removed from the dietary pattern, and the food were cooked at home for experimental subjects.

Also known as: dietary guidance
Specific Diet+ Partial Enteral Nutrition
EENOTHER

All energy and nutrients are obtained from exclusive enteral nutrition.

Exclusive Enteral Nutrition(EEN)

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnose CD according to endoscopy, histology and imaging;
  • Bowel resection for CD
  • Oral nutritional preparations or food can be given after surgery

You may not qualify if:

  • Plan operation within 5 weeks after surgery;
  • Presence of an ileostomy or colostomy
  • Complete bowel obstruction or fibrous stricture
  • Pregnancy or breastfeeding;
  • Plan to use biological agents within 5 weeks after surgery;
  • Plan to use corticosteroids or prednisone greater than 20 mg per day or equivalent doses of drugs to maintain remission within 5 weeks after surgery;
  • Plan to use probiotics or prebiotics for more than 1 week after surgery;
  • Antibiotics are used for more than 2 weeks after surgery;
  • Hypersensitivity to known components of enteral nutrition;
  • BMI less than 14 or greater than 28 kg/m2;
  • Celiac disease;
  • Complicated with other autoimmune diseases such as diabetes or rheumatic disease, autoimmune liver disease, psoriasis;
  • Mental illness;
  • Malignant tumors
  • Those who are not suitable for body composition analysis (such as pacemakers and metal objects in the body)
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

RECRUITING

MeSH Terms

Conditions

Crohn Disease

Interventions

Dietary Patterns

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaFeeding Behavior

Study Officials

  • yu qiao

    2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

    PRINCIPAL INVESTIGATOR
  • guo huilan

    2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2022

First Posted

August 16, 2022

Study Start

September 17, 2022

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

February 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations